Background Prior research has established some risk factors for an increased risk of severe
disease and mortality from coronavirus disease 2019 (COVID-19). However, the impact of …

Background Research on the immune response to inactivated COVID-19 vaccination among
people living with HIV (PLWH) is limited, especially among those with low CD4+ T …

Introduction: Exploring T cell response duration is pivotal for understanding immune
protection evolution in natural SARS-CoV-2 infections. The objective of the present study …

Objectives: We compared socio-demographic characteristics, health-related variables,
vaccination-related beliefs and attitudes, vaccination acceptance, and personality traits of …

Background COVID-19 vaccination was expected to reduce SARS-CoV-2 transmission, but
the relevance of this effect remains unclear. We aimed to estimate the effectiveness of …

The COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, is spreading
globally at an unprecedented rate. To protect the world against this devastating catastrophe …

Objective Vaccination is recognised as the most effective approach to contain the spread of
the COVID-19 pandemic in the long run. However, the global vaccination uptake is still …

Background: Since development of the first COVID-19 vaccine, the landscape of public
confidence in these vaccines is uncertain. Building confidence is crucial for better …

ABSTRACT COVID-19 appears to put people living with HIV and AIDS (PLWHA) at a higher
risk of catastrophic consequences and mortality. However, investigations on the hesitancy …

Background The effect of vaccination for COVID-19 on onward transmission is unknown.
Methods A national record linkage study determined documented COVID-19 cases and …